Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Sector Update: Healthcare Stocks Advance Friday Afternoon

Sector Update: Healthcare Stocks Advance Friday Afternoon

MT newswireMT newswire2026/11/06 17:39
01:39 PM EST, 11/06/2026 (MT Newswires) -- Healthcare stocks were higher Friday afternoon, with the NYSE Healthcare Index fractionally higher and the State Street Health Care Select Sector SPDR ETF (XLV) up about 0.5%. The iShares Biotechnology ETF (IBB) climbed up 2.3%. In corporate news, Moderna (MRNA) raised its full-year revenue growth outlook on Friday and swung to a surprise Q3 profit year over year amid strong international sales of its COVID-19 vaccine. Its shares jumped past 8%. Eli Lilly (LLY) and Hims & Hers Health (HIMS) said they signed an agreement to expand patient access to Eli Lilly's weight loss medicines Zepbound and Foundayo. Hims & Hers shares gained 7%, and Lilly was up 0.3%. Novartis (NVS) said testing has linked two tumor cases to its Zolgensma gene therapy, which treats spinal muscular atrophy, a rare genetic disease that causes progressive muscle weakness, Bloomberg reported. Novartis shares were up 0.6%.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The US FDA requires semaglutide, tirzepatide, and other GLP-1 drugs to include new warnings about the risk of eye disease.

NAION is an eye disease that can cause sudden, painless loss of vision, with some patients potentially experiencing permanent visual impairment. The drugs involved include products from Eli Lilly and Novo Nordisk. According to analysts at Citi, the incidence of NAION is relatively low, and given the significant benefits of GLP-1 drugs in weight control and blood sugar management, the actual impact on prescription behavior is expected to be limited. On Monday, the stock prices of Eli Lilly and Novo Nordisk increased, with the news not causing any significant impact on their share prices.

华尔街见闻•2026/11/09 22:12